<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">95427</article-id><article-id pub-id-type="doi">10.7554/eLife.95427</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.95427.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Noncaloric monosaccharides induce excessive sprouting angiogenesis in zebrafish via foxo1a-marcksl1a signal</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Xiaoning</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0222-0755</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhao</surname><given-names>Jinxiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xu</surname><given-names>Jiehuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Bowen</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Xia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5473-5596</contrib-id><email>liuxia_fd@ntu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xie</surname><given-names>Gangcai</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8286-2987</contrib-id><email>gangcai@ntu.edu.cn</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Duan</surname><given-names>Xuchu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4763-126X</contrib-id><email>dxd2002sk@ntu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Dong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2764-6544</contrib-id><email>liudongtom@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02afcvw97</institution-id><institution>Affiliated Hospital of Nantong University, Nantong Laboratory of Development and Diseases, School of Life Science; Co-innovation Center of Neuroregeneration, Nantong University</institution></institution-wrap><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution>Suqian First Hospital</institution><addr-line><named-content content-type="city">Suqian</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02afcvw97</institution-id><institution>Medical School, Nantong University</institution></institution-wrap><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Henrion</surname><given-names>Daniel</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04yrqp957</institution-id><institution>University of Angers</institution></institution-wrap><country>France</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>04</day><month>10</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP95427</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-01-18"><day>18</day><month>01</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-01-22"><day>22</day><month>01</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.01.18.576182"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-04-03"><day>03</day><month>04</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95427.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-09-09"><day>09</day><month>09</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95427.2"/></event></pub-history><permissions><copyright-statement>© 2024, Wang, Zhao, Xu et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Wang, Zhao, Xu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-95427-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-95427-figures-v1.pdf"/><abstract><p>Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced <italic>foxo1a</italic> mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of <italic>marcksl1a</italic>. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Consuming too much sugar can damage blood vessels and contribute to diseases like diabetes and heart disease. Artificial sweeteners have been suggested as a healthier alternative, and are now included in many products like sodas and baked goods.</p><p>However, some studies have suggested that people who consume large amounts of artificial sweeteners also have an increased risk of cardiovascular disease. Others suggest individuals may also experience spikes in blood sugar levels similar to those observed in people with diabetes. Yet few studies have examined how artificial sweeteners affect the network of vessels that transport blood and other substances around the body.</p><p>To investigate this question, Wang, Zhao, Xu, et al. studied zebrafish embryos which had been exposed to sugar and a type of artificial sweetener known as non-caloric monosaccharides<bold>.</bold> Various imaging tools revealed that high levels of sugar caused the embryos to produce more new blood vessels via a process called angiogenesis. This excessive growth of blood vessels has previously been linked to diabetic complications, including cardiovascular disease.</p><p>Wang, Zhao, Xu, et al. found that zebrafish embryos exposed to several different non-caloric monosaccharides developed similar blood vessel problems. All the sweeteners tested caused immature cells lining the blood vessels to develop into active tip cells that promote angiogenesis. This led to more new blood vessels forming that branch off already existing veins and arteries.</p><p>These findings suggest that artificial sweeteners may cause the same kind of damage to blood vessels as sugar. This may explain why people who consume a lot of artificial sweeteners are at risk of developing heart disease and high blood sugar levels. Future studies could help scientists learn more about how genetics or other factors affect the health impact of sugars and artificial sweeteners. This may lead to a greater understanding of the long-term health effects of artificially sweetened foods.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>noncaloric monosaccharides</kwd><kwd>endothelial cell activation</kwd><kwd>foxo1a</kwd><kwd>marcksl1a</kwd><kwd>zebrafish</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>2018YFA0801004</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Dong</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81870359</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Dong</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Live imaging and single-cell sequencing analyses on zebrafish models revealed that noncaloric monosaccharides and glucose similarly induce excessive blood vessel formation due to endothelial cells' increased formation of tip cells.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Diabetes mellitus (DM) encompasses a group of chronic diseases characterized by elevated blood glucose levels. Among patients with DM, cardiovascular complications, especially the direct and indirect effects of hyperglycemia on the human vascular network, persist as the primary cause of morbidity and mortality (<xref ref-type="bibr" rid="bib10">de Matheus et al., 2013</xref>). The harmful effects of hyperglycemia are closely associated with both microvascular and macrovascular complications, including retinopathy, nephropathy, neuropathy, atherosclerosis, ischemic heart disease, stroke, and peripheral artery disease (<xref ref-type="bibr" rid="bib16">Fox et al., 2004</xref>; <xref ref-type="bibr" rid="bib44">Rask-Madsen and King, 2013</xref>). Endothelial cell dysfunction is a systemic pathological state exhibiting disrupted integrity, adhesion, altered proliferation capacity, migration, tube formation, and more (<xref ref-type="bibr" rid="bib15">Flammer et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Kolluru et al., 2012</xref>). High blood glucose levels over long periods have been demonstrated to be associated with vascular dysfunction both in vivo and in vitro (<xref ref-type="bibr" rid="bib48">Tesfamariam et al., 1990</xref>; <xref ref-type="bibr" rid="bib49">Ting et al., 1996</xref>).</p><p>The epidemiological evidence has indicated the positive correlation between risks of cardiovascular disease and DM with the consumption of sugar-sweetened beverages (SSBs) and 100% fruit juices, thereby emphasizing the concerns for the adverse effects of sugar intake on cardiometabolic risk factors, regardless of whether the sugar is added or naturally occurring (<xref ref-type="bibr" rid="bib24">Imamura et al., 2015</xref>; <xref ref-type="bibr" rid="bib34">Malik, 2017</xref>; <xref ref-type="bibr" rid="bib38">Narain et al., 2016</xref>; <xref ref-type="bibr" rid="bib32">Larsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Fung et al., 2009</xref>). Artificially sweetened beverages (ASBs), which incorporate noncaloric sweeteners or low-caloric additives, have been suggested as healthy alternatives to SSBs (<xref ref-type="bibr" rid="bib14">Fakhouri et al., 2012</xref>). ASBs contain sugar alcohols and polyols, such as sorbitol, xylitol, maltitol, mannitol, erythritol, isomalt, and lactitol. The consumption of ASBs worldwide has gradually increased in recent years (<xref ref-type="bibr" rid="bib14">Fakhouri et al., 2012</xref>; <xref ref-type="bibr" rid="bib47">Sylvetsky et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Moriconi et al., 2020</xref>). However, accumulating studies in the last decade suggested that ASB consumption might be associated with an increased risk of cardiovascular events and diabetes (<xref ref-type="bibr" rid="bib17">Fung et al., 2009</xref>; <xref ref-type="bibr" rid="bib9">de Koning et al., 2012</xref>; <xref ref-type="bibr" rid="bib13">Fagherazzi et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Gardener et al., 2012</xref>; <xref ref-type="bibr" rid="bib11">Drouin-Chartier et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">de Koning et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Hirahatake et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Mossavar-Rahmani et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Vyas et al., 2015</xref>). Nevertheless, the underlying mechanisms responsible for these findings remain insufficiently documented.</p><p>The zebrafish has been recognized as a valuable animal model for studying metabolic diseases, such as hyperglycemia and diabetic complications, due to its functional conservation in glycol metabolism, pancreas structure, glucose homeostasis, adipose biology, and genetic similarities to mammals (<xref ref-type="bibr" rid="bib58">Zang et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Barros et al., 2008</xref>; <xref ref-type="bibr" rid="bib12">Elo et al., 2007</xref>). The combination of embryonic transparency and transgenic lines, wherein endothelial cells are labeled specifically with fluorescent proteins, facilitates the high-resolution imaging analysis of vascular formation in vivo. Immersion of zebrafish in glucose solution has been found to induce diabetic complications, including vascular dysfunction (<xref ref-type="bibr" rid="bib19">Gleeson et al., 2007</xref>; <xref ref-type="bibr" rid="bib2">Alvarez et al., 2010</xref>; <xref ref-type="bibr" rid="bib25">Jörgens et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Jung et al., 2016</xref>). Several recent studies have investigated the effects of high glucose on vascular function in the zebrafish model (<xref ref-type="bibr" rid="bib27">Jung et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Heckler and Kroll, 2017</xref>; <xref ref-type="bibr" rid="bib26">Jörgens et al., 2015</xref>). However, the association between noncaloric monosaccharides and vascular dysfunctions, such as excessive angiogenesis, has not been elucidated. Here, we have successfully established a short-term zebrafish model that exhibits significantly excessive angiogenesis similar to the phenotypes observed in proliferative diabetic retinopathy (PDR) induced by glucose treatment. Using this model, we examined the effects of noncaloric monosaccharides on blood vessel development and investigated the molecular mechanisms. Our results provided new evidence for the negative roles of caloric and noncaloric monosaccharides on vascular development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Establishment of a short-term model of high glucose-induced excessive angiogenesis</title><p>To establish the short-term zebrafish hyperangiogenenic model induced by high glucose treatment, we immersed the <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos, a transgenic line wherein the endothelial cells were labeled with membrane-bound GFP (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), in glucose solution within a wide range of concentrations and time windows (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). We subsequently measured the glucose concentration in the embryos. We found that the glucose concentration in the embryos treated with high glucose was significantly higher than that in the control group (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). We observed that exposing zebrafish embryos at either 24 hr post fertilization (hpf) or 48 hpf to a 6% D-glucose treatment for a duration exceeding 48 hr led to dramatically increased formation of blood vessels (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="video" rid="video1">Videos 1</xref> and <xref ref-type="video" rid="video2">2</xref>), especially intersegmental vessels (ISVs) in the indicated area (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). The hyperbranched endothelial cells were observed to sprout from existing vessels, including the ISVs, dorsal aorta (DA), and dorsal lateral anastomotic vessel (DLAV) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) in embryos treated with high glucose.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-95427-video1.mp4" id="video1"><label>Video 1.</label><caption><title>The 3D structure of the blood vessels in the control <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</title></caption></media><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Glucose treatment caused excessive angiogenesis in zebrafish.</title><p>(<bold>a</bold>) A diagram showing the glucose treatment time window and imaging time point. (<bold>b</bold>) A diagram indicating the imaging positions of the zebrafish embryos. (<bold>c</bold>) Confocal imaging analysis of the control and glucose-treated embryos. The red bar indicates position 1; the green bar indicates position 2. Arrowheads indicate the ectopic branching from the dorsal aorta. Stars indicate the ectopic vessels from intersegmental vessels (ISVs) and dorsal lateral anastomotic vessels (DLAVs). (<bold>d</bold>) Statistical analysis of the total length of ISVs in control and glucose-treated embryos (n=8). t-test, ****p&lt;0.0001. (<bold>e</bold>) A diagram showing the glucose treatment time window and imaging time point. (<bold>f</bold>) Confocal imaging analysis of the control and glucose-treated embryos. The red bar indicates position 1; the green bar indicates position 2. Arrowheads indicate the ectopic branching from the dorsal aorta. Stars indicate the ectopic vessels from ISVs and DLAVs. (<bold>g</bold>) Statistical analysis of the total length of ISVs in control and glucose-treated embryos (n=8). t-test, ****p&lt;0.0001. (<bold>h</bold>) A diagram showing the glucose treatment time window and imaging time point. (<bold>i</bold>) Confocal imaging analysis of the control and glucose-treated embryos. The red bar indicates position 1; the green bar indicates position 2. Arrowheads indicate the ectopic branching from the dorsal aorta. Stars indicate the ectopic vessels from ISVs and DLAVs. (<bold>j</bold>) Statistical analysis of the total length of ISVs in control and glucose-treated embryos (n=8). t-test<italic>,</italic> ****p&lt;0.0001. (<bold>k</bold>) A diagram showing the glucose treatment time window and imaging time point. (<bold>l</bold>) Confocal imaging analysis of the control and glucose-treated embryos. The red bar indicates position 1; the green bar indicates position 2. Arrowheads indicate the ectopic branching from the dorsal aorta. Stars indicate the ectopic vessels from ISVs and DLAVs. (<bold>m</bold>) Statistical analysis of the total length of ISVs in control and glucose-treated embryos (n=8). t-test, ****p&lt;0.0001. (<bold>o</bold>) A diagram showing the blood vessels in position 2 indicated in panel b of control embryos. (<bold>p</bold>) A diagram showing the blood vessels in position 2 indicated in panel b of high glucose-treated embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Confocal imaging analysis of <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos at 48 hr post fertilization (hpf) and 72 hpf.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>The diagrams show the glucose treatment time window and imaging time point.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Total glucose concentrations at different development stages in control and high glucose-treated embryos.</title><p>(<bold>a</bold>) A diagram showing the glucose treatment time window and concentration measuring time point. (<bold>b</bold>) Statistical analysis of the glucose concentration in control and high glucose-treated embryos. One-way ANOVA, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Stereo microscopic analysis of control, glucose, and sucrase-treated embryos in a bright field.</title><p>(<bold>a–c</bold>) Imaging analysis of control, glucose, and sucrase-treated embryos in bright field. (<bold>d</bold>) A diagram showing the sucrase treatment time window and imaging time point. (<bold>e</bold>) A diagram indicating the imaging positions of the zebrafish embryos. (<bold>f</bold>) Confocal imaging analysis of the control and sucrase-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. The red bar indicates position 1; the green bar indicates the position. (<bold>g</bold>) A diagram showing the sucrase treatment time window and imaging time point. (<bold>h</bold>) Confocal imaging analysis of the control and sucrase-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. The red bar indicates position 1; the green bar indicates the position.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig1-figsupp4-v1.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>Confocal imaging analysis of 1–4% glucose-treated blood vessels.</title><p>(<bold>a</bold>) A diagram showing the glucose treatment time window and imaging time point. (<bold>b–g’</bold>) Confocal imaging analysis of the control, 1%, 2%, 3%, and 4% glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig1-figsupp5-v1.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-95427-video2.mp4" id="video2"><label>Video 2.</label><caption><title>The 3D structure of the blood vessels in the glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</title></caption></media><p>Additionally, these ectopically branched angiogenic sprouts were not perfused by blood flow. Despite the abnormal vessel formation, no significant developmental defects were observed in these treated embryos when examined under a bright-field microscope (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4a–c</xref>). Moreover, no excessive angiogenic phenotype was observed in the embryos treated with 1%, 2%, 3%, and 4% D-glucose within the corresponding time frame (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>).</p></sec><sec id="s2-2"><title>Fructose and noncaloric monosaccharides induce excessive angiogenesis</title><p>Fructose is a ketonic monosaccharide that is an energy source for living organisms. Therefore, our study investigated the potential effects of fructose on vascular dysfunction in comparison to glucose. The result demonstrated fructose-induced excessive angiogenesis in zebrafish embryos (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Wondering whether the effects of glucose and fructose on vascular development were mediated by metabolic events, we then conducted the same tests by using other noncaloric monosaccharides, including L-glucose, D-mannose, D-ribose, and L-arabinose, which animals could not digest. Interestingly, we observed that all these noncaloric monosaccharides could induce excessive angiogenesis, among which the L-glucose purchased from two companies resulted in a similar phenotype as efficiently as D-glucose did (<xref ref-type="fig" rid="fig2">Figure 2a–h</xref>). To rule out the effect of osmotic pressure, we treated zebrafish embryos with isotonic disaccharides, including lactose, maltose, and sucrose, which did not cause a significant excessive angiogenic phenotype (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4d and h</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). However, higher concentration disaccharide treatment can also cause excessive angiogenesis in zebrafish embryos (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). In addition, we also tested the effects of pyruvic acid but did not observe the excessive angiogenic phenotype in the embryos treated with pyruvic acid solution at 50 nM to 50 μM concentration (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). Furthermore, we examined the arterial and venous identity of the hyperbranched vessels via live imaging analysis of the high glucose-treated <italic>Tg(flt1:YFP::kdrl:ras-mCherry</italic>) line, in which the YFP expression in the artery was relatively higher than that in the vein (<xref ref-type="bibr" rid="bib30">Krueger et al., 2011</xref>). The result revealed that the hyperbranched ectopic vessels comprised arteries and veins (<xref ref-type="fig" rid="fig2">Figure 2i and j</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>L-Glucose and mannose treatment caused excessive angiogenesis as well.</title><p>(<bold>a</bold>) A diagram showing the monosaccharides treatment time window and imaging time point. (<bold>b</bold>) A diagram indicating the imaging position of the zebrafish embryos. (<bold>c–g</bold>) Confocal imaging analysis of the control and monosaccharides, including L-glucose, D-mannose, D-ribose, and L-arabinose, treated embryos. Arrowheads indicate the ectopic branching from the dorsal aorta. Stars indicate the ectopic vessels from intersegmental vessels (ISVs). (<bold>h</bold>) Statistical analysis of the total length of ISVs in control and monosaccharides-treated embryos (n=5). (<bold>i, j</bold>) Confocal imaging analysis of the control and glucose-treated embryos. Arrowheads indicate the ectopic branching of arteries. Stars indicate the ectopic branching of veins. t-test, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Fructose treatment caused excessive angiogenesis in zebrafish.</title><p>(<bold>a</bold>) A diagram showing the fructose treatment time window and imaging time point. (<bold>b</bold>) A diagram indicating the imaging position of the zebrafish embryos. (<bold>c, d</bold>) Confocal imaging analysis of the control and glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>e, f</bold>) Imaging analysis of control and fructose-treated embryos in bright field.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Lactose and maltose treatment did not cause excessive angiogenesis in zebrafish.</title><p>(<bold>a</bold>) A diagram showing the lactose and maltose treatment time window and imaging time point. (<bold>b–d’’</bold>) Confocal imaging analysis of the control, lactose-, and maltose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Higher concentration sucrase and maltose treatment cause excessive angiogenesis in zebrafish embryos.</title><p>(<bold>a</bold>) A diagram showing the sucrase and maltose treatment time window and imaging time point. (<bold>b</bold>) Confocal imaging analysis of the control and sucrase-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>c</bold>) Statistical analysis of the total length of intersegmental vessels (ISVs) in control and sucrase-treated embryos (n=5). t-test, ****p&lt;0.0001. (<bold>d</bold>) Confocal imaging analysis of the control and maltose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Pyruvic acid treatment did not cause excessive angiogenesis in zebrafish.</title><p>(<bold>a</bold>) A diagram showing the pyruvic acid treatment time window and imaging time point. (<bold>b</bold>) Confocal imaging analysis of the pyruvic acid-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>c</bold>) A diagram showing the pyruvic acid treatment time window and imaging time point. (<bold>d</bold>) Confocal imaging analysis of the pyruvic acid-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig2-figsupp4-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>High glucose promotes quiescent endothelial differentiation into tip cells</title><p>Given that a high glucose shock has been observed to induce excessive angiogenesis in 48 hpf embryos, it was hypothesized that the shock might play a crucial role in regulating the differentiation of quiescent endothelial cells (ECs) into active tip cell-like cells and their subsequent behaviors. To investigate whether this was the case, we observed the behaviors of these ECs by confocal time-lapse imaging analysis. As shown in the result, in control <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos, no significant activation of tip cells in the angiogenic sprouts was observed in the generated ISVs, DA, and DLAV in the embryos aged from 48 hpf to 5 dpf. Moreover, only a few ECs in established ISVs, DA, and DLAV extended filopodia, which quickly retracted (<xref ref-type="fig" rid="fig3">Figure 3a–c</xref>, <xref ref-type="video" rid="video3">Video 3</xref>). However, many ECs initiated sprouting angiogenesis in the high glucose-treated embryos, extended dynamic filopodia to sense the surroundings, and formed excessive ectopic blood vessels (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="video" rid="video4">Video 4</xref>). In a snapshot, we observed that some of the ECs protruded long and intricate sprouts simultaneously (<xref ref-type="fig" rid="fig3">Figure 3f</xref>), and nearly all the ECs within an ISV underwent the outgrowth of filopodia in some extreme cases (<xref ref-type="fig" rid="fig3">Figure 3g</xref>), suggesting that the high glucose treatment induced the endothelial differentiation into tip cell-like cells. Furthermore, we observed that these outgrowths of the ectopic angiogenic sprouts could establish a connection to the neighboring sprouts and vessels and thereby form complicated vascular structures (<xref ref-type="fig" rid="fig1">Figure 1c, f, i, l, and p</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>High glucose treatment induced endothelial differentiation into tip cell-like cells.</title><p>(<bold>a</bold>) A diagram showing the confocal time-lapse imaging time window. (<bold>b</bold>) A diagram indicating the imaging position of the zebrafish embryos. (<bold>c</bold>) Confocal time-lapse imaging analysis of blood vessels in control <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>d</bold>) A diagram showing the glucose treatment time window and confocal time-lapse imaging time window. (<bold>e</bold>) Confocal time-lapse imaging analysis of blood vessels in glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. Arrowheads indicate the ectopic angiogenic branches. (<bold>f</bold>) A snapshot of confocal time-lapse imaging analysis of blood vessels in glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. Z stacks were used to make 3D color projections, where blue represents the most proximal (closest to the viewer), and red represents the most distal (farthest from the viewer). Arrowheads indicate ectopic angiogenic sprouts. (<bold>g</bold>) A snapshot of confocal time-lapse imaging analysis of an intersegmental vessel (ISV) in glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. Arrowheads indicate ectopic angiogenic sprouts. (<bold>h-j’</bold>) The feature plot of tip cell marker genes <italic>esm1</italic>, <italic>apln</italic> and <italic>cxcr4a</italic> of control and high glucose group in arterial and capillary ECs. (<bold>k</bold>) The violin plot of tip cell marker genes <italic>esm1</italic>, <italic>apln</italic> and <italic>cxcr4a</italic> of control and high glucose group in arterial and capillary ECs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig3-v1.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-95427-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Time-lapse imaging analysis of filopodia in the control <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</title></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-95427-video4.mp4" id="video4"><label>Video 4.</label><caption><title>Time-lapse imaging analysis of filopodia in the glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</title></caption></media></sec><sec id="s2-4"><title>Single-cell transcriptomic sequencing analysis of the ECs isolated from glucose-treated embryos</title><p>We did a single-cell transcriptomic sequencing analysis to gain more insight into the potential mechanism through which glucose activates the ECs. Due to the limited presence of ECs within the zebrafish embryos, the analysis of these cells poses a challenge. First, we isolated the EGFP-positive cells from control and high glucose-treated embryos. Following the proteolytic dissociation of embryos, the EGFP-positive cells were isolated by fluorescence-activated cell sorting. Around 300–500 zebrafish embryos were used for the ECs collection for each stage. The isolated ECs were analyzed using a large-scale scRNA-seq (10X Genomics) platform, and the pipeline is illustrated in the diagram (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Multiple criteria were applied to select the single cells, including the retention of the genes that were expressed (Unique Molecular Identifiers or UMI larger than 0) in at least three individual cells, the selection of cells with the gene expression count falling within the range of 500–3000, and the imposition of a threshold wherein the proportion of sequencing reads derived from the mitochondrial genome was limited to less than 5% (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Ultimately, 6006 ECs were selected for further analysis (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Single-cell transcriptome sequencing analysis of endothelial cells (ECs) in control and high glucose-treated embryos.</title><p>(<bold>a</bold>) Schematic diagram of the single-cell sequencing process. 300 embryos in the control group and 300 in the high glucose group were used, and ECs were sorted by GFP fluorescent using fluorescence-activated cell sorting (FACS) technology. (<bold>b</bold>) The measured cells were divided into six individual clusters based on gene expression profiles using UMAP. (<bold>c–h</bold>) The violin plots of some EC marker genes. (<bold>i</bold>) The proportion of ECs in each cluster of control and high glucose groups. (<bold>j</bold>) Changes of ECs percentage in arterial and capillary ECs, endocardium, and proliferating ECs of control and high glucose group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Overview of the number of genes, total Unique Molecular Identifiers (UMIs), and percentage of mitochondrial UMIs for the single-cell RNA sequencing.</title><p>(<bold>a</bold>) Before filtering. (<bold>b</bold>) After filtering. Cell selection criteria: 500&lt;number of genes&lt;3000; 0&lt;percentage of mitochondrial UMIs&lt;5%.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>UMAP representation of endothelial cell (EC) subpopulations.</title><p>All single cells (after filtering) from the control and D-glucose treated were included in this illustration.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Transcriptome sequencing analysis of control, high D-glucose-, and high L-glucose-treated embryos.</title><p>(<bold>a</bold>) The heatmap of differentially expressed genes (DEGs). (<bold>b</bold>) Volcano map of DEGs after high D-glucose treatment. (<bold>c</bold>) Volcano map of DEGs after high L-glucose treatment.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>The heatmap of metabolism-related genes.</title><p>(<bold>a</bold>) The heatmap of gluconeogenesis-related genes. (<bold>b</bold>) The heatmap of glycolysis-related genes. (<bold>c</bold>) The heatmap of oxidative phosphorylation-related genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig4-figsupp4-v1.tif"/></fig></fig-group><p>Through clustering analysis of gene expression, these ECs were categorized into six clusters using UMAP. These clusters include cluster 0, which consists of arterial and capillary ECs; cluster1, comprising endocardium; cluster2, consisting of venous and lymphatic ECs; cluster3, comprising arch ECs; cluster4, encompassing proliferating ECs; and cluster5, consisting of vesicle-enriched ECs (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). The endothelial marker gene <italic>cdh5</italic> was expressed in all the clusters (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). The notch ligand <italic>dlc</italic> was highly expressed in arterial, capillary ECs, and arch ECs (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). The <italic>dab2</italic> and <italic>prox1</italic> were mainly enriched in venous and lymphatic ECs (<xref ref-type="fig" rid="fig4">Figure 4e and f</xref>). The <italic>cdk1</italic>, a key player in cell cycle regulation, was specifically expressed in proliferating ECs (<xref ref-type="fig" rid="fig4">Figure 4h</xref>). It was revealed that the ratio of arterial and capillary ECs and proliferating ECs was increased in the high glucose-treated embryos (<xref ref-type="fig" rid="fig4">Figure 4i and j</xref>), consistent with the observation that glucose treatment resulted in excessive sprouting angiogenesis of ISVs. In addition, we examined tip cell marker genes in arterial and capillary ECs. The results showed that the expression of <italic>esm1</italic>, <italic>cxcr4a,</italic> and <italic>apln</italic> was significantly upregulated after high glucose treatment (<xref ref-type="fig" rid="fig3">Figure 3h–k</xref>), consistent with our observation that high glucose treatment induced the endothelial differentiation into tip cell-like cells (<xref ref-type="fig" rid="fig3">Figure 3f and g</xref>).</p><p>We also performed the whole embryo transcriptome sequencing after high D-glucose and L-glucose treatment. We analyzed and compared the differentially expressed genes (DEGs) of control, high D-glucose-treated, and high L-glucose-treated embryos. The results revealed that 1259 and 1074 genes were upregulated significantly in high D-glucose- and high L-glucose-treated embryos, respectively, compared with the control (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). After that, we analyzed the expression of the genes related to metabolic pathways and found significant alteration in the expression of several genes involved in gluconeogenesis, glycolysis, and oxidative phosphorylation (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>).</p></sec><sec id="s2-5"><title>Foxo1a was significantly downregulated in arterial and capillary ECs</title><p>To identify the potential molecules responsible for increasing the proportion of arterial and capillary ECs in the embryos treated with glucose, we analyzed and compared the DEGs in arterial and capillary ECs of control and glucose-treated ECs. The results revealed that 1201 genes were upregulated and 523 genes were downregulated significantly (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Gene ontology (GO) analysis revealed that these DEGs were enriched in several biological processes, including regulation of actin filament organization, blood vessel morphogenesis, development, angiogenesis, etc. (<xref ref-type="fig" rid="fig5">Figure 5b</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Foxo1a was involved in the excessive angiogenesis induced by high glucose treatment.</title><p>(<bold>a</bold>) The volcano plot of differential expression genes in arterial and capillary endothelial cells (ECs). The avg_log2FC greater than 1 was considered significant, including 523 downregulated genes (blue dots) and 1201 upregulated genes (red dots). (<bold>b</bold>) Gene ontology (GO) analysis of 523 downregulated genes in arterial and capillary ECs. (<bold>c</bold>) The feature plot of ECs marker gene pecam1 of control and high glucose group in arterial and capillary ECs. (<bold>c’</bold>) The violin plot of ECs marker gene pecam1 of control and high glucose group in arterial and capillary ECs. (<bold>d</bold>) The feature plot of gene foxo1a of control and high glucose group in arterial and capillary ECs. (<bold>d’</bold>) The violin plot of gene foxo1a of control and high glucose group in arterial and capillary ECs. (<bold>e</bold>) Average expression of gene pecam1 and foxo1a in control and high glucose group. (<bold>f</bold>) Whole-mount in situ hybridization analysis of foxo1a in control, high glucose-, and high L-glucose-treated embryos. (<bold>g</bold>) A diagram showing the foxo1 inhibitor treatment time window. (<bold>h</bold>) Confocal imaging analysis of control embryos, AS1842856-treated embryos, and foxo1a MO-injected embryos. Arrowheads indicate ectopic angiogenic sprouts. (<bold>i</bold>) Statistical analysis of the total length of intersegmental vessels (ISVs) in control embryos, AS1842856-treated embryos, and foxo1a MO-injected embryos (n=5). t-test, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig5-v1.tif"/></fig><p>Subsequently, we searched for transcription factors among the genes involved in the aforementioned biological processes that might participate in inducing excessive angiogenesis. It has been reported that the loss of function of <italic>foxo1a</italic> led to excessive angiogenesis (<xref ref-type="bibr" rid="bib53">Wilhelm et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Rudnicki et al., 2018</xref>). Our study also revealed that <italic>foxo1a</italic> was significantly downregulated in arterial and capillary ECs after high glucose treatment compared to the ECs marker gene <italic>pecam1</italic> (<xref ref-type="fig" rid="fig5">Figure 5c–e</xref>). The in situ hybridization (ISH) experiments further confirmed the decrease in <italic>foxo1a</italic> expression following treatment with high D-glucose and L-glucose (<xref ref-type="fig" rid="fig5">Figure 5f</xref>). To verify whether the downregulation of Foxo1a led to excessive angiogenesis in zebrafish embryos, we performed loss-of-function experiments targeting <italic>foxo1a</italic>. AS1842856, a cell-permeable inhibitor reported to block <italic>FOXO1</italic> transcription activity (<xref ref-type="bibr" rid="bib59">Zhao et al., 2019</xref>), was administered to zebrafish embryos at 48 hpf, and the imaging was performed at 72 hpf. The results revealed significantly excessive angiogenesis in AS1842856-treated embryos compared with the control group, consistent with the results obtained from <italic>foxo1a</italic> MO injection (<xref ref-type="fig" rid="fig5">Figure 5g–i</xref>).</p><p>To further validate that the excessive angiogenesis induced by high glucose was attributed to Foxo1a deficiency, we performed rescue experiments. In detail, <italic>foxo1a</italic> was overexpressed in either whole embryos or ECs, driven by <italic>hsp70l</italic> and <italic>fli1EP</italic> promoter, respectively. We injected the overexpression construct into one-cell stage embryos followed by heat shock at 24 hpf and 48 hpf. The embryos were then treated with high glucose from 48 hpf to 96 hpf (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). The results indicated that the gain of function of foxo1a in either whole embryos or ECs significantly and partially mitigated the excessive angiogenesis induced by high glucose treatment (<xref ref-type="fig" rid="fig6">Figure 6b–j</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Foxo1a gain of function can partially rescue the excessive angiogenesis induced by high glucose treatment.</title><p>(<bold>a</bold>) A diagram showing the high glucose treatment time window and heat shock-treated time point. (<bold>b</bold>) Confocal imaging analysis of blood vessels in control <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>c</bold>) Confocal imaging analysis of blood vessels in high glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>d–d’</bold>) Confocal imaging analysis of blood vessels in <italic>hsp70l:foxo1a-P2A-mCherry</italic> and high glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>e</bold>) Statistical analysis of the total length of intersegmental vessels (ISVs) in control, high glucose-treated, <italic>hsp70l:foxo1a-P2A-mCherry, and high glucose-</italic>treated embryos (n=6), respectively. One-way ANOVA, ****p&lt;0.0001. (<bold>f</bold>) A diagram showing the high glucose treatment time window and imaging time point. (<bold>g</bold>) Confocal imaging analysis of blood vessels in high glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>h</bold>) Confocal imaging analysis of blood vessels in <italic>fli1EP:foxo1a-mApple</italic> and high glucose-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>i</bold>) Statistical analysis of the number of sprouts per ISV in high glucose-treated embryos, and <italic>fli1EP:foxo1a-mApple</italic> and high glucose-treated embryos (n=9). t-test, ****p&lt;0.0001. (<bold>j</bold>) Statistical analysis of the total length of ISVs in high glucose-treated embryos, and <italic>fli1EP:foxo1a-mApple</italic> and high glucose-treated embryos (n=8). t-test, ***p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig6-v1.tif"/></fig></sec><sec id="s2-6"><title>Monosaccharides induced excessive angiogenesis through the <italic>foxo1a-marcksl1a</italic> pathway</title><p>A previous study has reported that <italic>marcksl1a</italic> overexpression in ECs in zebrafish led to a significant increase in filopodia formation, similar to the phenotype we observed in response to high glucose treatment (<xref ref-type="bibr" rid="bib29">Kondrychyn et al., 2020</xref>). Our analysis of the single-cell sequencing data revealed a significant upregulation of <italic>marcksl1a</italic> in arterial and capillary ECs following high glucose treatment, compared to the ECs marker gene <italic>kdrl</italic> (<xref ref-type="fig" rid="fig7">Figure 7a and b</xref>). The real-time quantitative PCR (qPCR) and ISH experiments further confirmed the elevated expression levels of <italic>marcksl1a</italic> following high D-glucose and L-glucose treatment (<xref ref-type="fig" rid="fig7">Figure 7c and d</xref>). Then, by constructing the transgenic zebrafish line <italic>hsp70l:marcksl1a-p2A-mCherry::Tg(fli1a:EGFP-CAAX) <sup>ntu666</sup></italic>, we conducted the experiments to overexpress <italic>marcksl1a</italic> in zebrafish and subsequently observed the vascular developmental phenotype. After 1 hr of heat shock at 24 hpf and confocal imaging analysis at 72 hpf, significantly increased blood vessel formation was observed in embryos overexpressing <italic>marcksl1a</italic>, compared with the control group (<xref ref-type="fig" rid="fig7">Figure 7e–g</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Marcksl1a overexpression induced excessive angiogenesis in zebrafish embryos.</title><p>(<bold>a</bold>) The violin plot of endothelial cells (ECs) marker gene <italic>kdrl</italic> of control and high glucose group in arterial and capillary ECs. (<bold>b</bold>) The violin plot of gene <italic>marcksl1a</italic> of control and high glucose group in arterial and capillary ECs. (<bold>c</bold>) Real-time PCR analysis of <italic>marcksl1a</italic> expression in control, high glucose-, and high L-glucose-treated embryos (n=6). t-test, ****p&lt;0.0001. (<bold>d</bold>) Whole-mount in situ hybridization analysis of <italic>marcksl1a</italic> in control, high glucose, and high L-glucose-treated embryos. (<bold>e–f’</bold>) Confocal imaging analysis of blood vessels in control and <italic>hsp70l:marcksl1a-P2A-mCherry</italic>-injected <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>g</bold>) Statistical analysis of the total length of intersegmental vessels (ISVs) in control and <italic>hsp70l:marcksl1a-P2A-mCherry</italic>-injected embryos (n=5). t-test, **p&lt;0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Multiple amino acid sequence alignment of mouse FOXO1 and zebrafish Foxo1a.</title><p>The DNA binding domain of mouse FOXO1 is demarcated with blue.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Confocal imaging analysis of blood vessels in the embryos with Lenvatinib treatment.</title><p>(<bold>a</bold>) A diagram showing the Lenvatinib treatment time window and imaging time point. (<bold>b</bold>) Confocal imaging analysis of the control and Lenvatinib-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos. (<bold>c</bold>) A diagram showing the Lenvatinib treatment time window and imaging time point. (<bold>d</bold>) Confocal imaging analysis of the control and Lenvatinib-treated <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> embryos.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig7-figsupp2-v1.tif"/></fig></fig-group><p>Given the results obtained from <italic>marcksl1a</italic> overexpression and loss of function of <italic>foxo1a</italic>, we hypothesized that <italic>marcksl1a</italic> might be a target gene of Foxo1a. Therefore, we investigated the impact of Foxo1 inhibition on <italic>marcksl1a</italic> expression in zebrafish embryos. As expected, qPCR analysis revealed that inhibition of Foxo1a by AS1842856 resulted in the upregulation of marcksl1a expression. In contrast, Foxo1a overexpression resulted in the downregulation of <italic>marcksl1a</italic> (<xref ref-type="fig" rid="fig8">Figure 8a–c</xref>), which suggested that Foxo1a might negatively regulate <italic>marcksl1a</italic> transcription in zebrafish. To further confirm it, we performed the chromatin immunoprecipitation (ChIP) experiment to validate the potential binding interaction between Foxo1 and <italic>marcksl1a</italic>. Since the amino acid sequence and DNA binding motifs of Foxo1 are highly conserved between zebrafish and mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>), we analyzed the 3 kb promoter region of <italic>marcksl1a</italic> to search the binding site (BS) sequence of mouse FOXO1 presented in the JASPAR database. Two candidate BS were found at −265 to −275 (BS1) and −153 to −163 (BS2) nucleotides upstream of the TSS of <italic>marcksl1a</italic> (<xref ref-type="fig" rid="fig8">Figure 8d</xref>) and then used for the ChIP-PCR assay detection. The results showed that Foxo1a was enriched in both the predicted binding sites of <italic>marcksl1a</italic> (<xref ref-type="fig" rid="fig8">Figure 8e</xref>) in zebrafish. Luciferase reporter assay also indicated that Foxo1a could negatively regulate marcksl1a transcription in zebrafish (<xref ref-type="fig" rid="fig8">Figure 8f and g</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Noncaloric monosaccharides induced excessive angiogenesis through foxo1a-marcksl1a signal in zebrafish embryos.</title><p>(<bold>a</bold>) A diagram showing the Foxo1 inhibitor and heat shock treatment time window. (<bold>b</bold>) Real-time PCR analysis of <italic>marcksl1a</italic> expression in control and AS1842856-treated embryos (n=3). t-test, ***p<italic>&lt;</italic>0.001. (<bold>c</bold>) Real-time PCR analysis of <italic>marcksl1a</italic> expression in control and <italic>foxo1a</italic> overexpressed embryos (n=3). t-test, **p<italic>&lt;</italic>0.01. (<bold>d</bold>) A sequence logo of Foxo1-binding sequence presented in the JASPAR database (<ext-link ext-link-type="uri" xlink:href="https://jaspar.genereg.net/">https://jaspar.genereg.net/</ext-link>) and two candidate binding sites at the upstream of transcription start site (TSS) of <italic>marcksl1a</italic> in zebrafish. (<bold>e</bold>) Results of the chromatin immunoprecipitation (ChIP)-PCR assay indicated that BS1 and BS2 are Foxo1a-binding sites of <italic>marcksl1a</italic> in zebrafish. Input sonicated genomic DNA samples without immunoprecipitation as a positive control. IgG, sonicated, and IgG-immunoprecipitated genomic DNA samples as a negative control. (<bold>f, g</bold>) Luciferase reporter activity in <italic>foxo1a</italic> overexpressed or knocked down embryos (n=3), respectively. t-test, **p<italic>&lt;</italic>0.01, ****p&lt;0.0001. (<bold>h–m</bold>) Confocal imaging analysis of blood vessels in control, high glucose, high glucose and Lenvatinib, high glucose+<italic>marcksl1a</italic> MO, high L-glucose, and high L-glucose+<italic>marcksl1a</italic> MO groups. (<bold>n</bold>) Statistical analysis of the total length of intersegmental vessels (ISVs) in the groups in h–m (n=6), respectively. One-way ANOVA, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-fig8-v1.tif"/></fig><p>Additionally, we microinjected <italic>marcksl1a</italic> MO into the one-cell stage <italic>Tg(fli1a:EGFP-CAAX) <sup>ntu666</sup></italic> embryos, which were then treated with high levels of D-glucose and L-glucose. The findings revealed that the knockdown of Marcksl1a could effectively mitigate the excessive angiogenesis caused by high D-glucose or high L-glucose treatment, resembling the rescue effect observed with VEGFR inhibitor Lenvatinib (<xref ref-type="fig" rid="fig8">Figure 8h–n</xref>, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). These results suggested that monosaccharides induced excessive angiogenesis through the Foxo1a-<italic>marcksl1a</italic> pathway in zebrafish embryos.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we successfully established a new zebrafish model with significant excessive angiogenesis, resembling the hyperangiogenic characteristics observed in PDR more closely than previously established models (<xref ref-type="bibr" rid="bib27">Jung et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Jörgens et al., 2015</xref>). Jung et al. have described a short-term zebrafish model for diabetic retinopathy (DR) induced by high glucose, which exhibited blood vessel defects (<xref ref-type="bibr" rid="bib27">Jung et al., 2016</xref>). However, these defects were limited to the disruption of tight junctions and dilation of hyaloid-retinal vessels (<xref ref-type="bibr" rid="bib27">Jung et al., 2016</xref>), without the excessive angiogenesis and vascular blockage observed in PDR and our established model. Additionally, although Jörgens et al. have observed the hyperbranching of small vessel structures originating from the upper part of ISVs, growing horizontally toward and partially connecting to the neighboring ISVs field (<xref ref-type="bibr" rid="bib26">Jörgens et al., 2015</xref>), the angiogenic sprouts did not form a more complex structure that was observed in our research.</p><p>The excessive development of immature blood vessels represents a significant pathological condition in the progression of DR and nephropathy (<xref ref-type="bibr" rid="bib54">Wilkinson-Berka, 2004</xref>; <xref ref-type="bibr" rid="bib40">Osterby and Nyberg, 1987</xref>). Hyperglycemia has been considered one of the most causal factors causing vascular damage, including excessive angiogenesis. However, the exact mechanism through which hyperglycemia impairs the blood vessels is not well determined. We analyzed single-cell transcriptomic sequencing data of the ECs isolated from D-glucose-treated embryos to gain more insights into it. The findings revealed an increased ratio of tip cells and proliferating ECs, accompanied by the altered expression of various angiogenic genes in the ECs of D-glucose-treated embryos.</p><p>Foxo1 has been validated to be essential for sustaining the quiescence of ECs, with involvement in metabolism regulation (<xref ref-type="bibr" rid="bib53">Wilhelm et al., 2016</xref>; <xref ref-type="bibr" rid="bib3">Andrade et al., 2021</xref>). Moreover, it also plays an important role in diabetic microvascular complications, including DR (<xref ref-type="bibr" rid="bib41">Parmar et al., 2023</xref>; <xref ref-type="bibr" rid="bib5">Behl et al., 2022</xref>). Here, by combining the single-cell transcriptomic sequencing data analysis and experimental validation, we identified the transcription factor Foxo1a, which was significantly downregulated in the embryos treated with high glucose, responsible for the excessive angiogenesis. Additionally, our result further revealed that Foxo1a exerts its regulatory function during this process by downregulating its target gene <italic>marcksl1a</italic>, regardless of whether the embryos were treated with D-glucose or L-glucose. Taken together, our results suggested that both caloric and noncaloric monosaccharides treatment could lead to excessive angiogenesis by promoting the differentiation of quiescent ECs into tip cells through the <italic>foxo1a-marcksl1a</italic> pathway.</p><p>Previous studies have linked the consumption of ASB to the occurrence and development of cardiovascular disease (<xref ref-type="bibr" rid="bib17">Fung et al., 2009</xref>; <xref ref-type="bibr" rid="bib9">de Koning et al., 2012</xref>; <xref ref-type="bibr" rid="bib13">Fagherazzi et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Gardener et al., 2012</xref>; <xref ref-type="bibr" rid="bib11">Drouin-Chartier et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">de Koning et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Hirahatake et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Mossavar-Rahmani et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Vyas et al., 2015</xref>). However, the potential mechanisms underlying the association have not been well documented. In recent years, positive associations between ASB and cardiovascular disease have been proposed, possibly due to several plausible factors, including the potential impact of ASBs on central nervous system circuits, gut hormone secretion, and gut microbiota (<xref ref-type="bibr" rid="bib6">Blundell and Hill, 1986</xref>; <xref ref-type="bibr" rid="bib42">Pepino, 2015</xref>; <xref ref-type="bibr" rid="bib39">Nettleton et al., 2016</xref>). Additionally, it has been hypothesized that the ASBs might stimulate appetite and increase calorie intake (<xref ref-type="bibr" rid="bib6">Blundell and Hill, 1986</xref>; <xref ref-type="bibr" rid="bib42">Pepino, 2015</xref>).</p><p>For a long time, there has been considerable debate and conflicting opinions regarding how specific sugars affect the development of type 2 diabetes rather than excess calories per se (<xref ref-type="bibr" rid="bib43">Qi and Tester, 2020</xref>; <xref ref-type="bibr" rid="bib33">Laville and Nazare, 2009</xref>). In this study, we have provided new evidence indicating that the administration of noncaloric monosaccharides leads to significant excessive angiogenesis, suggesting that the excessive angiogenesis may not be only attributed to the caloric properties. Since excessive angiogenesis is the major pathological feature of DR and nephropathy, our findings are in support of a possible biological mechanism underlying the positive associations between noncaloric monosaccharides and microvascular complications associated with type 2 diabetes, suggesting that the noncaloric monosaccharides might not be suitable for ASB consumption.</p><p>Surprisingly, no notable abnormalities were observed in the vessels of embryos treated with disaccharides, including lactose, maltose, and sucrose, which is consistent with the previous study stating that intakes of sucrose, lactose, and maltose were not significantly associated with the risk of type 2 diabetes (<xref ref-type="bibr" rid="bib35">Montonen et al., 2007</xref>). This finding implied that the effects induced by monosaccharides cannot be attributed to the osmotic pressure of the surrounding medium. Furthermore, despite the potential conversion of these disaccharides into monosaccharides, the restricted reaction rate may maintain them within a safe concentration range that is not harmful to the vessels in a short period.</p><p>In conclusion, to investigate the effects of monosaccharides on vascular development, we established a zebrafish model by treating the embryos with high concentrations of monosaccharides. Based on this model, we observed significant excessive angiogenesis induced by glucose and noncaloric monosaccharides, initiated by activating the quiescent ECs into proliferating tip cells. The effects of monosaccharides on inducing excessive angiogenesis were then proved to be mediated by the <italic>foxo1a-marcksl1a</italic> pathway. The results have provided novel insights into the roles of noncaloric monosaccharides in human health and the underlying mechanisms.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Zebrafish</title><p>Care and breeding of zebrafish were carried out as previously described (<xref ref-type="bibr" rid="bib52">Wang et al., 2016</xref>). Animal experiments were conducted according to local institutional laws and Chinese law for the Protection of Animals. The following transgenic strains were used: <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> and <italic>Tg(kdrl:ras-mCHerry)</italic> (<xref ref-type="bibr" rid="bib30">Krueger et al., 2011</xref>). Embryos were obtained through natural mating and maintained at 28.5°C. The stages of zebrafish embryos are defined as previously described (<xref ref-type="bibr" rid="bib52">Wang et al., 2016</xref>). Embryos were treated with 0.2 mM 1-phenyl-2-thiourea (PTU, Sigma, P7629) to block pigmentation for further imaging analysis.</p></sec><sec id="s4-2"><title>Monosaccharides and drug treatment</title><p>The D-glucose (Sigma, G7021-100g), L-glucose (Sigma, G5500-1g; J&amp;K, 981195-1g), D-fructose (Sigma, F0127-100g), L-rhamnose monohydrate (Aladdin, R108982), D-sorbitol (Sigma, S1876-100g), D-mannitol (Sigma, M4125-100g), D-(-)-ribose (Sigma, V900389-25g), L-(+)-arabinos (Sigma, V900920-25g), mannose (Sigma, M2069-25g), and sucrose (Sigma, V900116-500G) were dissolved in E3 solution. Zebrafish embryos at 24 hpf to 48 hpf were placed in 24-well plates (10 embryos per well) and immersed in the solution at the presetting concentrations and time windows. Then, put it in a 28°C incubator for cultivation. Five days before embryonic development, a stereo fluorescence microscope and a laser confocal microscope were used to observe the changes in blood vessel phenotype. For the drug treatment, the embryos were co-incubated in glucose with Lenvatinib (Selleck, S1164-5MG) at the presetting concentrations and time window. Foxo1 inhibitor AS1842856 (MCE, HY-100596) was dissolved in DMSO and stored at –80°C and diluted with E3 solution to 1 μM when used. The same concentration of DMSO was used as a negative control.</p></sec><sec id="s4-3"><title>Glucose concentration measurement</title><p>Glucose concentration in the embryo was measured as described previously (<xref ref-type="bibr" rid="bib7">Da’as et al., 2023</xref>). Embryos that developed to 75% epiboly were selected and transferred to 24-well plates (10 embryos per well) and immersed in the solution at the presetting concentrations and time windows. For glucose concentration measurement, embryos (n=20) were transferred to a new 1.5 mL tube, rinsed three times with 1× PBS, and immersed in ice for the following experiments. Discard the PBS as much as possible, embryos homogenized using a hand homogenizer, and centrifuged at 14,000×<italic>g</italic> for 10 min. 1.5 μL of the supernatant was used to measure the total free-glucose level using a glucometer (Baye, 7600P).</p></sec><sec id="s4-4"><title>Whole-mount ISH</title><p>Whole-mount ISH and the preparation of antisense RNA probes were performed as described in the previous protocol (<xref ref-type="bibr" rid="bib23">Huang et al., 2013</xref>). Briefly, the <italic>marcksl1a</italic> and <italic>foxo1a</italic> cDNA fragments were cloned with the specific primers listed below using the wild-type embryo (AB) cDNA library. Probes were synthesized using the in vitro DIG-RNA labeling transcription Kit (Roche, 11175025910) with linearized pGEM-T easy vector containing <italic>marcksl1a</italic> or <italic>foxo1a</italic> gene fragment as the templates. Synthesized probes were purified with LiCl (Invitrogen, AM9480) and diluted to 1 ng/µL for hybridization. Zebrafish embryos were collected and fixed with 4% paraformaldehyde overnight at 4°C, then dehydrated with methanol gradients and stored at –20°C in 100% methanol. The hybridization result was detected with anti-DIG-AP antibody (1:2000, Roche, 11093274910) and NBT/BCIP (1:500, Roche, 11681451001). After hybridization, images of the embryos were captured with an Olympus stereomicroscope MVX10. The primers are listed below:</p><list list-type="simple"><list-item><p><italic>marcksl1a</italic>-probe-forward:5’- <named-content content-type="sequence">AGG ATG GGT GCT CAG TTG AC</named-content>-3’</p></list-item><list-item><p><italic>marcksl1a</italic>-probe-reverse:5’- <named-content content-type="sequence">GCT GGC GTC TCA TTG GTT TC</named-content>-3’</p></list-item><list-item><p><italic>foxo1a</italic>-probe-forward:5’-<named-content content-type="sequence">GCA ACA CAG GAT TTC CCC AC</named-content>-3’</p></list-item><list-item><p><italic>foxo1a</italic>-probe-reverse:5’-<named-content content-type="sequence">CAC AGG TGG CAC TGG AAG G</named-content>-3’</p></list-item></list></sec><sec id="s4-5"><title>Single-cell gene expression profile analysis</title><p>Cell Ranger 3.0.2 (<ext-link ext-link-type="uri" xlink:href="https://github.com/10XGenomics/cellranger">https://github.com/10XGenomics/cellranger</ext-link>; <xref ref-type="bibr" rid="bib1">10xGenomics Company, 2019</xref>) was used to convert the raw sequencing data to a single-cell level gene count matrix. The clustering of single cells and the marker genes in each cluster were analyzed by Seurat 3.0 (<ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/install.html">https://satijalab.org/seurat/install.html</ext-link>; <xref ref-type="bibr" rid="bib46">Stuart et al., 2019</xref>). Several criteria were applied to select the single cells, including only keeping the genes that are expressed (UMI larger than 0) at least in three single cells, selecting single cells with the number of expressed genes at the range between 500 and 3000, and requiring the percentage of sequencing reads on mitochondrial genome being less than 5 percentage. Furthermore, sctransform method (<xref ref-type="bibr" rid="bib20">Hafemeister and Satija, 2019</xref>) was applied to remove technical variation, and ClusterProfiler (<xref ref-type="bibr" rid="bib56">Yu et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Yu et al., 2019</xref>) was used to do the GO enrichment analysis based on the marker genes of each cell cluster. Detailed information about the data processing can be found in this project’s source code (<ext-link ext-link-type="uri" xlink:href="https://github.com/gangcai/ZebEndoimmune">https://github.com/gangcai/ZebEndoimmune</ext-link>; <xref ref-type="bibr" rid="bib55">Xie, 2024</xref>).</p></sec><sec id="s4-6"><title>Gene expression analysis by real-time qPCR</title><p>Total RNA was extracted from zebrafish embryos using TRIzol (Invitrogen, 15596026) and stored at –80°C. The cDNA was then synthesized using the HiScript II Q RT SuperMix for qPCR Kit (Vazyme, R223-01) according to the manufacturer’s instructions. qPCR was performed in triplicates using the Taq Pro Universal SYBR qPCR Master Mix (Vazyme, Q712-02) on a real-time PCR detection system (StepOne Real-Time PCR Systems). The primers used for real-time PCR analysis are as follows:</p><list list-type="simple"><list-item><p><italic>ef1α</italic>-Qpcr-F:5’- <named-content content-type="sequence">CTT CAA CGC TCA GGT CAT CA</named-content> -3’</p></list-item><list-item><p><italic>ef1α</italic>-Qpcr-R:5’- <named-content content-type="sequence">CGG TCG ATC TTC TCC TTG AG</named-content> -3</p></list-item><list-item><p><italic>marcksl1a</italic>-Qpcr-F:5’-<named-content content-type="sequence"> CCG TGG CTG ATA AAG CCA AT</named-content> -3’</p></list-item><list-item><p><italic>marcksl1a</italic>-Qpcr-R:5’- <named-content content-type="sequence">CTC CCT CCT CCG TTT TTG GG</named-content> -3’</p></list-item></list></sec><sec id="s4-7"><title>Transgenic and heat shock</title><p>The <italic>Tg(fli1aEP:EGFP-CAAX)<sup>ntu666</sup></italic> line was established using a construct <italic>fli1aEP:EGFP-CAAX</italic>, which was generated using MultiSite Gateway technology, the tol2 kit as previously described (<xref ref-type="bibr" rid="bib31">Kwan et al., 2007</xref>). The 5’ Entry p5Efli1ep (#31160) purchased from Addgene was originally from Nathan Lawson Lab (<xref ref-type="bibr" rid="bib50">Villefranc et al., 2007</xref>). Three entry clones and the pDestTol2pA2 destination vector were used to generate the expression construct by LR recombination reaction as described in the Multisite Gateway Manual book. The expression constructs were synthesized by GENEWIZ company. The zebrafish embryos were immersed in a 37°C water bath for 1 hr for heat shock. Around 75 pg of expression plasmid DNA and 25 pg tol2 transposase mRNA were premixed and microinjected into single-cell fertilized eggs.</p></sec><sec id="s4-8"><title>ChIP-PCR</title><p>Embryos injected with <italic>hsp70l:foxo1a-6×His-P2A-mCherry</italic> were collected at 72 hpf after heat shock treatment. According to the manufacturer’s instructions, the ChIP-PCR assay was performed using the ChIP Assay Kit (Millipore, 3753379). The genomic DNA crossed with Foxo1a protein was immunoprecipitated by using 5 μg Anti-6×His tag antibody (abcam, ab213204). Antibody against lgG was used as a negative control. The semiquantitative PCR was performed with KODfx (TOYOBO, KFX-101) at the following conditions: 94°C for 5 min; 35 cycles of 98°C for 10 s, 55°C for 30 s, 68°C for 10 s; 68°C for 10 min. The PCR primers used for the predicted BS are as follows:</p><list list-type="simple"><list-item><p><italic>marcksl1a</italic>-BS1-forward:5’- <named-content content-type="sequence">CCC TTT TTC AAA AGT GAG TTT GAG</named-content> -3’</p></list-item><list-item><p><italic>marcksl1a</italic> -BS1-reverse:5’- <named-content content-type="sequence">GGA GCT TCA TCT GCC CCA TT</named-content> -3’</p></list-item><list-item><p><italic>marcksl1a</italic> -BS2-forward:5’- <named-content content-type="sequence">CGG TTT CCA GCT TTC TTC AGA A</named-content> 3’</p></list-item><list-item><p><italic>marcksl1a</italic> -BS2-reverse:5’-<named-content content-type="sequence"> TCT CAA ACT CAC TTT TGA AAA AGG G</named-content> -3’</p></list-item></list></sec><sec id="s4-9"><title>Luciferase reporter assay</title><p>Plasmids of PGL4.10[luc2] and PGL4.74[hRluc/TK] (Promega) were used for luciferase reporter assay. Zebrafish <italic>marcksl1a</italic> promoter fragment with predictive Foxo1a-binding cite was cloned and inserted into pGL4.10 basic vector by Kpn I and Hind III. The assays for detecting the promoter activity in response to Foxo1a were performed according to the previous study. Briefly, 50 pg of PGL4.10 vectors, 1 pg of PGL4.74 vectors, and 50 pg of <italic>foxo1a</italic> mRNA or 20 pg of <italic>foxo1a</italic> MO were co-injected into wild-type embryos at the one-cell stage. And then, embryos were harvested at 24 hpf to measure their luciferase activity according to the manufacturer’s protocols (Promega).</p></sec><sec id="s4-10"><title>Imaging analysis</title><p>For confocal imaging of blood vessels in fluorescence protein labeled transgenic zebrafish embryos, they were anesthetized with egg water/0.16 mg/mL MS222 (Sigma, A5040)/1% PTU and embedded in 0.5–0.8% low melting agarose. Confocal imaging was performed with a Nikon A1R HD25 Confocal Microscope. Analysis was performed using Nikon-NIS-Elements software. The bright-field images were acquired with an Olympus DP71 camera on an Olympus stereomicroscope MVX10.</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Statistical analysis was performed with a Student’s t-test. All data is presented as mean ± SEM; p&lt;0.05 was considered statistically significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Visualization</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Resources, Software</p></fn><fn fn-type="con" id="con5"><p>Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Software, Project administration</p></fn><fn fn-type="con" id="con7"><p>Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All zebrafish experimentation was carried out following the NIH Guidelines for the care and use of laboratory animals (<ext-link ext-link-type="uri" xlink:href="http://oacu.od.nih.gov/regs/index.htm">http://oacu.od.nih.gov/regs/index.htm</ext-link>) and ethically approved by the Administration Committee of Experimental Animals, Jiangsu Province, China (Approval ID: 20180905-002).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Cell proportions and numbers of each cluster.</title></caption><media xlink:href="elife-95427-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Cell proportions and numbers of each cluster.</title></caption><media xlink:href="elife-95427-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-95427-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE276251 and GSE276252.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Single-cell transcriptome sequencing analysis of endothelial cells in control and high glucose treated zebrafish embryos</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276251">GSE276251</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Effect of D-glucose and L-glucose on gene expression of zebrafish embryos at 72 hpf (hours post fertilization) and 96 hpf</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276252">GSE276252</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This study was supported by grants from the National Natural Science Foundation of China (81870359, 2018YFA0801004).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="software"><person-group person-group-type="author"><collab>10xGenomics Company</collab></person-group><year iso-8601-date="2019">2019</year><data-title>Cell ranger</data-title><version designator="3.0.2">3.0.2</version><source>Genomics</source><ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/support/software/cell-ranger">https://www.10xgenomics.com/support/software/cell-ranger</ext-link></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Reynolds</surname><given-names>AL</given-names></name><name><surname>Waghorne</surname><given-names>N</given-names></name><name><surname>O’Connor</surname><given-names>JJ</given-names></name><name><surname>Kennedy</surname><given-names>BN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy</article-title><source>Disease Models &amp; Mechanisms</source><volume>3</volume><fpage>236</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1242/dmm.003772</pub-id><pub-id pub-id-type="pmid">20142328</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Costa</surname><given-names>ASH</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Doddaballapur</surname><given-names>A</given-names></name><name><surname>Sugino</surname><given-names>T</given-names></name><name><surname>Ong</surname><given-names>YT</given-names></name><name><surname>Castro</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>B</given-names></name><name><surname>Kaulich</surname><given-names>M</given-names></name><name><surname>Guenther</surname><given-names>S</given-names></name><name><surname>Wilhelm</surname><given-names>K</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Koh</surname><given-names>GY</given-names></name><name><surname>Grosso</surname><given-names>AR</given-names></name><name><surname>Frezza</surname><given-names>C</given-names></name><name><surname>Potente</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Control of endothelial quiescence by FOXO-regulated metabolites</article-title><source>Nature Cell Biology</source><volume>23</volume><fpage>413</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00637-6</pub-id><pub-id pub-id-type="pmid">33795871</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>TP</given-names></name><name><surname>Alderton</surname><given-names>WK</given-names></name><name><surname>Reynolds</surname><given-names>HM</given-names></name><name><surname>Roach</surname><given-names>AG</given-names></name><name><surname>Berghmans</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Zebrafish: An emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery</article-title><source>British Journal of Pharmacology</source><volume>154</volume><fpage>1400</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1038/bjp.2008.249</pub-id><pub-id pub-id-type="pmid">18552866</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behl</surname><given-names>T</given-names></name><name><surname>Wadhwa</surname><given-names>M</given-names></name><name><surname>Sehgal</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Bhatia</surname><given-names>S</given-names></name><name><surname>Al-Harrasi</surname><given-names>A</given-names></name><name><surname>Aleya</surname><given-names>L</given-names></name><name><surname>Bungau</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mechanistic insights into the role of FOXO in diabetic retinopathy</article-title><source>American Journal of Translational Research</source><volume>14</volume><fpage>3584</fpage><lpage>3602</lpage><pub-id pub-id-type="pmid">35836845</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>JE</given-names></name><name><surname>Hill</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Paradoxical effects of an intense sweetener (aspartame) on appetite</article-title><source>Lancet</source><volume>1</volume><fpage>1092</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(86)91352-8</pub-id><pub-id pub-id-type="pmid">2871354</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da’as</surname><given-names>SI</given-names></name><name><surname>Ahmed</surname><given-names>I</given-names></name><name><surname>Hasan</surname><given-names>WH</given-names></name><name><surname>Abdelrahman</surname><given-names>DA</given-names></name><name><surname>Aliyev</surname><given-names>E</given-names></name><name><surname>Nisar</surname><given-names>S</given-names></name><name><surname>Bhat</surname><given-names>AA</given-names></name><name><surname>Joglekar</surname><given-names>MV</given-names></name><name><surname>Hardikar</surname><given-names>AA</given-names></name><name><surname>Fakhro</surname><given-names>KA</given-names></name><name><surname>Akil</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature</article-title><source>Journal of Translational Medicine</source><volume>21</volume><elocation-id>171</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-023-03893-2</pub-id><pub-id pub-id-type="pmid">36869348</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Koning</surname><given-names>L</given-names></name><name><surname>Malik</surname><given-names>VS</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men</article-title><source>The American Journal of Clinical Nutrition</source><volume>93</volume><fpage>1321</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.3945/ajcn.110.007922</pub-id><pub-id pub-id-type="pmid">21430119</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Koning</surname><given-names>L</given-names></name><name><surname>Malik</surname><given-names>VS</given-names></name><name><surname>Kellogg</surname><given-names>MD</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men</article-title><source>Circulation</source><volume>125</volume><fpage>1735</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.067017</pub-id><pub-id pub-id-type="pmid">22412070</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Matheus</surname><given-names>AM</given-names></name><name><surname>Tannus</surname><given-names>LRM</given-names></name><name><surname>Cobas</surname><given-names>RA</given-names></name><name><surname>Palma</surname><given-names>CCS</given-names></name><name><surname>Negrato</surname><given-names>CA</given-names></name><name><surname>de Gomes</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Impact of diabetes on cardiovascular disease: an update</article-title><source>International Journal of Hypertension</source><volume>2013</volume><elocation-id>653789</elocation-id><pub-id pub-id-type="doi">10.1155/2013/653789</pub-id><pub-id pub-id-type="pmid">23533715</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drouin-Chartier</surname><given-names>JP</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Malik</surname><given-names>V</given-names></name><name><surname>Pan</surname><given-names>A</given-names></name><name><surname>Bhupathiraju</surname><given-names>SN</given-names></name><name><surname>Tobias</surname><given-names>DK</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Changes in consumption of sugary beverages and artificially sweetened beverages and subsequent risk of type 2 diabetes: Results from three large prospective U.S. cohorts of women and men</article-title><source>Diabetes Care</source><volume>42</volume><fpage>2181</fpage><lpage>2189</lpage><pub-id pub-id-type="doi">10.2337/dc19-0734</pub-id><pub-id pub-id-type="pmid">31582428</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elo</surname><given-names>B</given-names></name><name><surname>Villano</surname><given-names>CM</given-names></name><name><surname>Govorko</surname><given-names>D</given-names></name><name><surname>White</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Larval zebrafish as a model for glucose metabolism: expression of phosphoenolpyruvate carboxykinase as a marker for exposure to anti-diabetic compounds</article-title><source>Journal of Molecular Endocrinology</source><volume>38</volume><fpage>433</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1677/JME-06-0037</pub-id><pub-id pub-id-type="pmid">17446233</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagherazzi</surname><given-names>G</given-names></name><name><surname>Vilier</surname><given-names>A</given-names></name><name><surname>Saes Sartorelli</surname><given-names>D</given-names></name><name><surname>Lajous</surname><given-names>M</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Clavel-Chapelon</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale-European Prospective Investigation into Cancer and Nutrition cohort</article-title><source>The American Journal of Clinical Nutrition</source><volume>97</volume><fpage>517</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.050997</pub-id><pub-id pub-id-type="pmid">23364017</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhouri</surname><given-names>THI</given-names></name><name><surname>Kit</surname><given-names>BK</given-names></name><name><surname>Ogden</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Consumption of diet drinks in the United States, 2009‒2010</article-title><source>NCHS Data Brief</source><volume>1v</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23102235</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flammer</surname><given-names>AJ</given-names></name><name><surname>Anderson</surname><given-names>T</given-names></name><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Deanfield</surname><given-names>J</given-names></name><name><surname>Ganz</surname><given-names>P</given-names></name><name><surname>Hamburg</surname><given-names>NM</given-names></name><name><surname>Lüscher</surname><given-names>TF</given-names></name><name><surname>Shechter</surname><given-names>M</given-names></name><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Vita</surname><given-names>JA</given-names></name><name><surname>Lerman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The assessment of endothelial function: From research into clinical practice</article-title><source>Circulation</source><volume>126</volume><fpage>753</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.093245</pub-id><pub-id pub-id-type="pmid">22869857</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Coady</surname><given-names>S</given-names></name><name><surname>Sorlie</surname><given-names>PD</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>D’Agostino</surname><given-names>RB</given-names><suffix>Sr</suffix></name><name><surname>Wilson</surname><given-names>PWF</given-names></name><name><surname>Savage</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Trends in cardiovascular complications of diabetes</article-title><source>JAMA</source><volume>292</volume><fpage>2495</fpage><lpage>2499</lpage><pub-id pub-id-type="doi">10.1001/jama.292.20.2495</pub-id><pub-id pub-id-type="pmid">15562129</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>TT</given-names></name><name><surname>Malik</surname><given-names>V</given-names></name><name><surname>Rexrode</surname><given-names>KM</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sweetened beverage consumption and risk of coronary heart disease in women</article-title><source>The American Journal of Clinical Nutrition</source><volume>89</volume><fpage>1037</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2008.27140</pub-id><pub-id pub-id-type="pmid">19211821</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardener</surname><given-names>H</given-names></name><name><surname>Rundek</surname><given-names>T</given-names></name><name><surname>Markert</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>CB</given-names></name><name><surname>Elkind</surname><given-names>MSV</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study</article-title><source>Journal of General Internal Medicine</source><volume>27</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1007/s11606-011-1968-2</pub-id><pub-id pub-id-type="pmid">22282311</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>M</given-names></name><name><surname>Connaughton</surname><given-names>V</given-names></name><name><surname>Arneson</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Induction of hyperglycaemia in zebrafish (<italic>Danio rerio</italic>) leads to morphological changes in the retina</article-title><source>Acta Diabetologica</source><volume>44</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1007/s00592-007-0257-3</pub-id><pub-id pub-id-type="pmid">17721755</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>296</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1874-1</pub-id><pub-id pub-id-type="pmid">31870423</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckler</surname><given-names>K</given-names></name><name><surname>Kroll</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Zebrafish as a model for the study of microvascular complications of diabetes and their mechanisms</article-title><source>International Journal of Molecular Sciences</source><volume>18</volume><elocation-id>2002</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18092002</pub-id><pub-id pub-id-type="pmid">28925940</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirahatake</surname><given-names>KM</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names></name><name><surname>Shikany</surname><given-names>JM</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>ND</given-names></name><name><surname>Steffen</surname><given-names>LM</given-names></name><name><surname>Odegaard</surname><given-names>AO</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cumulative intake of artificially sweetened and sugar-sweetened beverages and risk of incident type 2 diabetes in young adults: the Coronary Artery Risk Development In Young Adults (CARDIA) Study</article-title><source>The American Journal of Clinical Nutrition</source><volume>110</volume><fpage>733</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1093/ajcn/nqz154</pub-id><pub-id pub-id-type="pmid">31374564</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Nonmuscle myosin II-B (myh10) expression analysis during zebrafish embryonic development</article-title><source>Gene Expression Patterns</source><volume>13</volume><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.gep.2013.04.005</pub-id><pub-id pub-id-type="pmid">23665442</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname><given-names>F</given-names></name><name><surname>O’Connor</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Mursu</surname><given-names>J</given-names></name><name><surname>Hayashino</surname><given-names>Y</given-names></name><name><surname>Bhupathiraju</surname><given-names>SN</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction</article-title><source>BMJ</source><volume>351</volume><elocation-id>h3576</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.h3576</pub-id><pub-id pub-id-type="pmid">26199070</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jörgens</surname><given-names>K</given-names></name><name><surname>Hillebrands</surname><given-names>JL</given-names></name><name><surname>Hammes</surname><given-names>HP</given-names></name><name><surname>Kroll</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Zebrafish: A model for understanding diabetic complications</article-title><source>Experimental and Clinical Endocrinology &amp; Diabetes</source><volume>120</volume><fpage>186</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1304565</pub-id><pub-id pub-id-type="pmid">22402952</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jörgens</surname><given-names>K</given-names></name><name><surname>Stoll</surname><given-names>SJ</given-names></name><name><surname>Pohl</surname><given-names>J</given-names></name><name><surname>Fleming</surname><given-names>TH</given-names></name><name><surname>Sticht</surname><given-names>C</given-names></name><name><surname>Nawroth</surname><given-names>PP</given-names></name><name><surname>Hammes</surname><given-names>H-P</given-names></name><name><surname>Kroll</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>High tissue glucose alters intersomitic blood vessels in zebrafish via methylglyoxal targeting the VEGF receptor signaling cascade</article-title><source>Diabetes</source><volume>64</volume><fpage>213</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.2337/db14-0352</pub-id><pub-id pub-id-type="pmid">25092676</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>S-H</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>Y-R</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy</article-title><source>British Journal of Pharmacology</source><volume>173</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/bph.13279</pub-id><pub-id pub-id-type="pmid">26276677</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolluru</surname><given-names>GK</given-names></name><name><surname>Bir</surname><given-names>SC</given-names></name><name><surname>Kevil</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing</article-title><source>International Journal of Vascular Medicine</source><volume>2012</volume><elocation-id>918267</elocation-id><pub-id pub-id-type="doi">10.1155/2012/918267</pub-id><pub-id pub-id-type="pmid">22611498</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondrychyn</surname><given-names>I</given-names></name><name><surname>Kelly</surname><given-names>DJ</given-names></name><name><surname>Carretero</surname><given-names>NT</given-names></name><name><surname>Nomori</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Chong</surname><given-names>J</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Okuda</surname><given-names>S</given-names></name><name><surname>Mochizuki</surname><given-names>N</given-names></name><name><surname>Phng</surname><given-names>L-K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Marcksl1 modulates endothelial cell mechanoresponse to haemodynamic forces to control blood vessel shape and size</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5476</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19308-5</pub-id><pub-id pub-id-type="pmid">33127887</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Scholz</surname><given-names>K</given-names></name><name><surname>Zimmer</surname><given-names>A</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Siekmann</surname><given-names>A</given-names></name><name><surname>Schulte-Merker</surname><given-names>S</given-names></name><name><surname>Cudmore</surname><given-names>M</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>le Noble</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo</article-title><source>Development</source><volume>138</volume><fpage>2111</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1242/dev.063933</pub-id><pub-id pub-id-type="pmid">21521739</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>KM</given-names></name><name><surname>Fujimoto</surname><given-names>E</given-names></name><name><surname>Grabher</surname><given-names>C</given-names></name><name><surname>Mangum</surname><given-names>BD</given-names></name><name><surname>Hardy</surname><given-names>ME</given-names></name><name><surname>Campbell</surname><given-names>DS</given-names></name><name><surname>Parant</surname><given-names>JM</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name><name><surname>Kanki</surname><given-names>JP</given-names></name><name><surname>Chien</surname><given-names>C-B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3088</fpage><lpage>3099</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21343</pub-id><pub-id pub-id-type="pmid">17937395</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>SC</given-names></name><name><surname>Akesson</surname><given-names>A</given-names></name><name><surname>Wolk</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sweetened beverage consumption is associated with increased risk of stroke in women and men</article-title><source>The Journal of Nutrition</source><volume>144</volume><fpage>856</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.3945/jn.114.190546</pub-id><pub-id pub-id-type="pmid">24717367</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laville</surname><given-names>M</given-names></name><name><surname>Nazare</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Diabetes, insulin resistance and sugars</article-title><source>Obesity Reviews</source><volume>10 Suppl 1</volume><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/j.1467-789X.2008.00562.x</pub-id><pub-id pub-id-type="pmid">19207533</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sugar sweetened beverages and cardiometabolic health</article-title><source>Current Opinion in Cardiology</source><volume>32</volume><fpage>572</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1097/HCO.0000000000000439</pub-id><pub-id pub-id-type="pmid">28639973</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montonen</surname><given-names>J</given-names></name><name><surname>Järvinen</surname><given-names>R</given-names></name><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Heliövaara</surname><given-names>M</given-names></name><name><surname>Reunanen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence</article-title><source>The Journal of Nutrition</source><volume>137</volume><fpage>1447</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.1093/jn/137.6.1447</pub-id><pub-id pub-id-type="pmid">17513405</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriconi</surname><given-names>E</given-names></name><name><surname>Feraco</surname><given-names>A</given-names></name><name><surname>Marzolla</surname><given-names>V</given-names></name><name><surname>Infante</surname><given-names>M</given-names></name><name><surname>Lombardo</surname><given-names>M</given-names></name><name><surname>Fabbri</surname><given-names>A</given-names></name><name><surname>Caprio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuroendocrine and metabolic effects of low-calorie and non-calorie sweeteners</article-title><source>Frontiers in Endocrinology</source><volume>11</volume><elocation-id>444</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2020.00444</pub-id><pub-id pub-id-type="pmid">32765425</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossavar-Rahmani</surname><given-names>Y</given-names></name><name><surname>Kamensky</surname><given-names>V</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Silver</surname><given-names>B</given-names></name><name><surname>Rapp</surname><given-names>SR</given-names></name><name><surname>Haring</surname><given-names>B</given-names></name><name><surname>Beresford</surname><given-names>SAA</given-names></name><name><surname>Snetselaar</surname><given-names>L</given-names></name><name><surname>Wassertheil-Smoller</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Artificially sweetened beverages and stroke, coronary heart disease, and all-cause mortality in the women’s health initiative</article-title><source>Stroke</source><volume>50</volume><fpage>555</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.118.023100</pub-id><pub-id pub-id-type="pmid">30802187</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narain</surname><given-names>A</given-names></name><name><surname>Kwok</surname><given-names>CS</given-names></name><name><surname>Mamas</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: A systematic review and meta-analysis</article-title><source>International Journal of Clinical Practice</source><volume>70</volume><fpage>791</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1111/ijcp.12841</pub-id><pub-id pub-id-type="pmid">27456347</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nettleton</surname><given-names>JE</given-names></name><name><surname>Reimer</surname><given-names>RA</given-names></name><name><surname>Shearer</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Reshaping the gut microbiota: Impact of low calorie sweeteners and the link to insulin resistance?</article-title><source>Physiology &amp; Behavior</source><volume>164</volume><fpage>488</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2016.04.029</pub-id><pub-id pub-id-type="pmid">27090230</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterby</surname><given-names>R</given-names></name><name><surname>Nyberg</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy</article-title><source>The Journal of Diabetic Complications</source><volume>1</volume><fpage>122</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/s0891-6632(87)80069-7</pub-id><pub-id pub-id-type="pmid">2456298</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parmar</surname><given-names>UM</given-names></name><name><surname>Jalgaonkar</surname><given-names>MP</given-names></name><name><surname>Kansara</surname><given-names>AJ</given-names></name><name><surname>Oza</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Emerging links between FOXOs and diabetic complications</article-title><source>European Journal of Pharmacology</source><volume>960</volume><elocation-id>176089</elocation-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2023.176089</pub-id><pub-id pub-id-type="pmid">37838103</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepino</surname><given-names>MY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Metabolic effects of non-nutritive sweeteners</article-title><source>Physiology &amp; Behavior</source><volume>152</volume><fpage>450</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2015.06.024</pub-id><pub-id pub-id-type="pmid">26095119</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Tester</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lactose, maltose, and sucrose in health and disease</article-title><source>Molecular Nutrition &amp; Food Research</source><volume>64</volume><elocation-id>e1901082</elocation-id><pub-id pub-id-type="doi">10.1002/mnfr.201901082</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask-Madsen</surname><given-names>C</given-names></name><name><surname>King</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Vascular complications of diabetes: Mechanisms of injury and protective factors</article-title><source>Cell Metabolism</source><volume>17</volume><fpage>20</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.11.012</pub-id><pub-id pub-id-type="pmid">23312281</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudnicki</surname><given-names>M</given-names></name><name><surname>Abdifarkosh</surname><given-names>G</given-names></name><name><surname>Nwadozi</surname><given-names>E</given-names></name><name><surname>Ramos</surname><given-names>SV</given-names></name><name><surname>Makki</surname><given-names>A</given-names></name><name><surname>Sepa-Kishi</surname><given-names>DM</given-names></name><name><surname>Ceddia</surname><given-names>RB</given-names></name><name><surname>Perry</surname><given-names>CG</given-names></name><name><surname>Roudier</surname><given-names>E</given-names></name><name><surname>Haas</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial-specific FoxO1 depletion prevents obesity-related disorders by increasing vascular metabolism and growth</article-title><source>eLife</source><volume>7</volume><elocation-id>e39780</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39780</pub-id><pub-id pub-id-type="pmid">30511639</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sylvetsky</surname><given-names>AC</given-names></name><name><surname>Welsh</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>RJ</given-names></name><name><surname>Vos</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Low-calorie sweetener consumption is increasing in the United States</article-title><source>The American Journal of Clinical Nutrition</source><volume>96</volume><fpage>640</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.034751</pub-id><pub-id pub-id-type="pmid">22854409</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesfamariam</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>ML</given-names></name><name><surname>Deykin</surname><given-names>D</given-names></name><name><surname>Cohen</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta</article-title><source>The Journal of Clinical Investigation</source><volume>85</volume><fpage>929</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1172/JCI114521</pub-id><pub-id pub-id-type="pmid">2312734</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>HH</given-names></name><name><surname>Timimi</surname><given-names>FK</given-names></name><name><surname>Boles</surname><given-names>KS</given-names></name><name><surname>Creager</surname><given-names>SJ</given-names></name><name><surname>Ganz</surname><given-names>P</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus</article-title><source>The Journal of Clinical Investigation</source><volume>97</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1172/JCI118394</pub-id><pub-id pub-id-type="pmid">8550838</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villefranc</surname><given-names>JA</given-names></name><name><surname>Amigo</surname><given-names>J</given-names></name><name><surname>Lawson</surname><given-names>ND</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Gateway compatible vectors for analysis of gene function in the zebrafish</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3077</fpage><lpage>3087</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21354</pub-id><pub-id pub-id-type="pmid">17948311</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vyas</surname><given-names>A</given-names></name><name><surname>Rubenstein</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Seguin</surname><given-names>RA</given-names></name><name><surname>Vitolins</surname><given-names>MZ</given-names></name><name><surname>Kazlauskaite</surname><given-names>R</given-names></name><name><surname>Shikany</surname><given-names>JM</given-names></name><name><surname>Johnson</surname><given-names>KC</given-names></name><name><surname>Snetselaar</surname><given-names>L</given-names></name><name><surname>Wallace</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Diet drink consumption and the risk of cardiovascular events: A report from the Women’s health initiative</article-title><source>Journal of General Internal Medicine</source><volume>30</volume><fpage>462</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1007/s11606-014-3098-0</pub-id><pub-id pub-id-type="pmid">25515135</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ling</surname><given-names>CC</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>You</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Chai</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MicroRNA-10a/10b represses a novel target gene mib1 to regulate angiogenesis</article-title><source>Cardiovascular Research</source><volume>110</volume><fpage>140</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvw023</pub-id><pub-id pub-id-type="pmid">26825552</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>K</given-names></name><name><surname>Happel</surname><given-names>K</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Schoors</surname><given-names>S</given-names></name><name><surname>Oellerich</surname><given-names>MF</given-names></name><name><surname>Lim</surname><given-names>R</given-names></name><name><surname>Zimmermann</surname><given-names>B</given-names></name><name><surname>Aspalter</surname><given-names>IM</given-names></name><name><surname>Franco</surname><given-names>CA</given-names></name><name><surname>Boettger</surname><given-names>T</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Fruttiger</surname><given-names>M</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Potente</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FOXO1 couples metabolic activity and growth state in the vascular endothelium</article-title><source>Nature</source><volume>529</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1038/nature16498</pub-id><pub-id pub-id-type="pmid">26735015</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson-Berka</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Vasoactive factors and diabetic retinopathy: Vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide</article-title><source>Current Pharmaceutical Design</source><volume>10</volume><fpage>3331</fpage><lpage>3348</lpage><pub-id pub-id-type="doi">10.2174/1381612043383142</pub-id><pub-id pub-id-type="pmid">15544519</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>ZebEndoimmune</data-title><version designator="0.1.0">0.1.0</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/gangcai/ZebEndoimmune">https://github.com/gangcai/ZebEndoimmune</ext-link></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>Omics</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>ClusterProfiler</data-title><version designator="3.14.3">3.14.3</version><source>Bioconductor</source><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/3.10/bioc/html/clusterProfiler.html">https://www.bioconductor.org/packages/3.10/bioc/html/clusterProfiler.html</ext-link></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname><given-names>L</given-names></name><name><surname>Maddison</surname><given-names>LA</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Zebrafish as a Model for Obesity and Diabetes</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>6</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2018.00091</pub-id><pub-id pub-id-type="pmid">30177968</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Ying</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y-C</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>TP</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Pan</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition</article-title><source>Cell Research</source><volume>29</volume><fpage>895</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1038/s41422-019-0229-5</pub-id><pub-id pub-id-type="pmid">31501519</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95427.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Henrion</surname><given-names>Daniel</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Angers</institution><country>France</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This <bold>valuable</bold> study investigates the effect of noncaloric monosaccharides, sugar substitutes that are commonly used by diabetic patients, on angiogenesis in the zebrafish embryo. The authors show that noncaloric monosaccharides and glucose similarly induce excessive blood vessel formation due to the increased formation of tip cells by endothelial cells through the foxo1a-marcksl1a pathway. This <bold>solid</bold> study is of interest for the medical community in charge of the prevention and of the treatment of diabetes and other metabolic diseases.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95427.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Dong Liu et al. successfully established a short-term zebrafish model by treating the embryos with high concentrations of monosaccharides, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy. The authors found that excessive angiogenesis induced by glucose and noncaloric monosaccharides can be achieved by activating the quiescent endothelial cells into proliferating tip cells. Importantly, the authors further confirmed the effects of monosaccharides on inducing excessive angiogenesis were mediated by the foxo1a-marcksl1a pathway. These results demonstrate the potentially detrimental effects of the noncaloric monosaccharides on blood vessel function and provided novel insights into the underlying mechanisms.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95427.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>In the manuscript Liu et al. observed that glucose and noncaloric monosaccharides can prompt an excessive formation of blood vessels, particularly intersegmental vessels (ISVs). They propose that these branched vessels arise from the ectopic activation of quiescent endothelial cells (ECs) into tip cells. Moreover, through single-cell transcriptome sequencing analysis of embryonic endothelial cells exposed to glucose, they noted an increased proportion of arterial and capillary endothelial cells, proliferative endothelial cells, along with a series upregulated genes in categories of blood vessel morphogenesis, development, and pro-angiogenesis. The authors provide evidence suggesting that caloric and noncaloric monosaccharides (NMS) induce excessive angiogenesis via the Foxo1a-Marcksl1a pathway.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95427.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors have investigated the effect of noncaloric monosaccharides on angiogenesis in the zebra fish embryo. These compounds are used as substitutes of sugars to sweeten beverages and they are commonly used by diabetic patients. The authors show that noncaloric monosaccharides and glucose similarly induce excessive blood vessels formation due to increased formation of tip cells by endothelial cells. The authors show that this excessive angiogenesis involved the foxo1a-marcksl1a pathway.</p><p>A limitation of the study is that the mechanism of angiogenesis in the retinal circulation and in peripheral vasculature is certainly different.</p><p>This result suggests that these noncaloric monosaccharides share common side effects with glucose. Consequently, more caution should be taken as regard to the use of these artificial sweeteners. This work is of interest for a better management of diabetes.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95427.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xiaoning</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Jinxiang</given-names></name><role specific-use="author">Author</role><aff><institution>Suqian First Hospital</institution><addr-line><named-content content-type="city">Suqian</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jiehuan</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Bowen</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xia</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Gangcai</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Duan</surname><given-names>Xuchu</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dong</given-names></name><role specific-use="author">Author</role><aff><institution>Nantong University</institution><addr-line><named-content content-type="city">Nantong</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1:</bold></p><p>(1) The authors claimed that they examined the arterial and venous identity of the hyperbranched vessels via live imaging analysis of the high glucose-treated Tg(flt1:YFP::kdrl:ras-mCherry) line, and revealed that the hyperbranched ectopic vessels comprised arteries and veins. That's good, of course. However, there are no relevant results in Figure 2. Please revise it.</p></disp-quote><p>Thank you very much for the suggestion. We’ve added this part of the results in Figure 2i and j.</p><disp-quote content-type="editor-comment"><p>(2) In Figures 3f and 3g, some of the ECs protruded long and intricate sprouts, and nearly all the ECs within an ISV underwent the outgrowth of filopodia in some extreme cases (Figure 3g), suggesting that the high glucose treatment induced the endothelial differentiation into tip cell-like cells. The findings are surprising and interesting. In order to further confirm the author's conclusion, in situ hybridization experiments are more appropriate to show the expression changes of tip cell-like cell marker genes in the high glucose-treated embryos.</p></disp-quote><p>Thank you very much for your constructive suggestions. We have performed the analysis of single-cell RNA-seq data, and the results showed that the tip cell marker genes such as <italic>esm1</italic>, <italic>apln</italic>, and <italic>cxcr4a</italic> were significantly up-regulated in arterial and capillary ECs after high glucose treatment. The results were integrated into Figure 3 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(3) Embryos treated with AS1842856 or injected with foxo1a-MO exhibited excessive angiogenesis (Figure 5g-i), suggesting the transcription activity of foxo1 is required to maintain the quiescent state of endothelial cells. Did the downregulation of foxo1a lead to the differentiation of endothelial cells into tip-cell-like cells?</p></disp-quote><p>Thank you very much for the question. We examined our results carefully and marked these tip cell-like cells with arrow heads in Figure 5h of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(4) Foxo1a was significantly downregulated in arterial and capillary ECs after high glucose treatment (Figure 5c-e). More importantly, whether overexpression of foxo1a in the high glucose-treated embryos could eliminate the hyperangiogenic characteristics?</p></disp-quote><p>Thank you for the great questions. We performed rescue experiments, and the results suggested that the overexpression of <italic>foxo1a</italic> partially mitigated the excessive angiogenesis induced by high glucose treatment. These results were integrated into Figure 6 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(5) The authors' results found that foxo1a was enriched in both the predicted binding sites of marcksl1a by ChIP-PCR experiments (Figure 7d). This result is reliable. However, whether these two sites are important for marcksl1a gene transcription needs to be confirmed by relevant experiments, such as luciferase reporter assays.</p></disp-quote><p>We’ve performed the luciferase reporter assays and added these data to Figure 8f and g.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2:</bold></p><p>Suggested major experiments:</p><p>(1) A previous study (Jorgens et al., Diabetes 64, 2015) reported that high tissue glucose levels increased reactive dicarbonyl methylglyoxal (MG) concentrations in zebrafish embryos and triggered the formation of hyperbranched ISVs. Additionally, they illustrated that MG induced the vascular hyperbranching phenotype via enhancing phosphorylated VEGFR and pAKT signaling cascade. The authors must examine whether both pVEGFR and pAKT are increased in noncaloric monosaccharide (NMS)-treated embryos. The authors need also to test the crosstalks between VEGFR/AKT signaling and foxo1a-Marcksl1a pathway in glucose or NMS-treated embryos.</p></disp-quote><p>Thank you very much for your suggestion. We treated the embryos with AS1842856 (foxo1 inhibitor) and Lenvatinib (VEGFR inhibitor), and the results showed that Lenvatinib treatment attenuated the excessive angiogenesis induced by foxo1 inhibition. We also examined the expression level of vegfaa after AS1842856 treatment; the results suggested that foxo1 inhibition did not affect the expression of vegfaa.</p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95427-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(2) In this manuscript, the authors performed single endothelial cell sequencing in glucose-treated embryos, and found reduced foxo1a expression and upregulated marcksl1a . Based on these data, the authors demonstrated that glucose and NMS-induced excessive angiogenesis through the foxo1a-marcksl1a pathway. The authors must conduct endothelial scRNA-seq in NMS-treated embryos, and analyze and compare the datasets with scRNA-seq datasets from glucose-treated endothelial cells, considering the focus of the paper. In addition, ASBs have been suggested as healthy alternatives to sugar-sweetened beverages. The authors also need to examine carefully whether metabolic gene programs are altered in glucose-treated endothelial cells, which was mentioned in Jorgens et al paper.</p></disp-quote><p>Thank you very much for your constructive suggestions. We have performed the whole embryo transcriptome sequencing after high D-glucose and L-glucose treatment. We analyzed and compared the differentially expressed genes of control, high D-glucose-treated, and high L-glucose-treated embryos. The results revealed that 1259 and 1074 genes were up-regulated significantly in high D-glucose and high L-glucose treated embryos, respectively, compared with control.</p><p>We also analyzed some metabolic-related genes and found that some genes involved in gluconeogenesis, glycolysis, and oxidative phosphorylation were significantly changed. The results were integrated into supplementary Figure12 and 13 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(3) Glucose or NMS treatments induce the hyperbranched endothelial vessels from the dorsal aorta and ISVs but not cardinal veins. In Figure 4i, the arterial and capillary cell population is increased in glucose-treated embryos, but the venous cell population seems to be reduced. The authors need to check whether arterial/venous differentiation and proliferation are affected in glucose- and NMS-treated embryos.</p></disp-quote><p>Thank you for your suggestions. We examined arterial/venous differentiation based on Tg(<italic>flt1BAC:YFP::kdrl:ras-mCherry</italic>) zebrafish line, in which the YFP is mainly expressed in arterial Endothelial cells. We found the endothelial cells of excessively formed blood vessels induced by high glucose treatment are mainly arterial (Figure 2j). This might explain why the arterial and capillary cell population was increased in glucose-treated embryos.</p><disp-quote content-type="editor-comment"><p>(4) The manuscript proposes that excessively branched vessels within ISVs arise from the ectopic activation of quiescent endothelial cells (ECs) into tip cells. To confirm this process, the authors need to detect some specific tip cell markers to demonstrate their ectopic activation.</p></disp-quote><p>Thank you for your constructive suggestions. We have performed the analysis of single-cell RNA-seq data, and the results showed that the tip cell marker genes such as <italic>esm1</italic>, <italic>apln</italic>, and <italic>cxcr4a</italic> were significantly up-regulated in arterial and capillary ECs after high glucose treatment. The results were integrated into Figure 3 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(5) Disaccharides such as lactose, maltose, and sucrose did not exhibit a notable induction of excessive angiogenic phenotype. However, the specific treatment concentrations utilized in the study were not delineated. Therefore, further investigation is warranted to determine whether increased disaccharide concentrations can cause vascular hyperbranching phenotype.</p></disp-quote><p>Thank you very much for the suggestions. We’ve described the concentrations of monosaccharides and disaccharides in the materials and methods section of the revised manuscript. Following the suggestion, we treated zebrafish embryos with a higher concentration of the disaccharide. The results showed that higher concentrations of disaccharide treatment also caused excessive angiogenesis in zebrafish embryos. These results were integrated into supplementary Figure 8 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(6) The authors claim that glucose and NMS (such as L-glucose) induce excessive angiogenesis through the foxo1a-marcksl1a pathway. Following exposure to elevated glucose levels, a substantial down-regulation of foxo1a was observed in arterial and capillary endothelial cells. This down-regulation led to the release of foxo1a inhibition on marccksl1a, subsequently resulting in an augmented expression of marccksl1a and the manifestation of a vascular phenotype. Consequently, it is imperative to investigate whether the foxo1a overexpression can attenuate marccksl1a expression and mitigate the vascular phenotype induced by monosaccharides. Sufficient data support is needed for the conclusion that monosaccharides induce angiogenesis via the foxo1a-marcksl1a pathway.</p></disp-quote><p>Thank you very much for your constructive suggestions.</p><p>We confirmed the expression of <italic>marcksl1a</italic> in foxo1a-overexpressed embryos. The results indicated that foxo1a overexpression significantly attenuated <italic>marcksl1a</italic> expression. The results were integrated into Figure 8c. We also performed the rescue experiments, which indicated that overexpression of <italic>foxo1a</italic> partially mitigated the excessive angiogenesis induced by high glucose treatment. These results were integrated into Figure 6 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Minor corrections:</p><p>(1) Figure 2i, j has no corresponding graphs.</p></disp-quote><p>We’ve made the change in Figure 2.</p><disp-quote content-type="editor-comment"><p>(2) Figure 2h has no vertical coordinates.</p></disp-quote><p>We’ve made the change in Figure 2.</p><disp-quote content-type="editor-comment"><p>(3) All Figures should be referenced within the manuscript.</p></disp-quote><p>We’ve checked our manuscript carefully and made the corrections.</p><disp-quote content-type="editor-comment"><p>(4) The concentrations of monosaccharides and disaccharides employed in this study must be distinctly elucidated within the manuscript and annotated using the internationally recognized unit notation.</p></disp-quote><p>We’ve checked our manuscript carefully and described the concentrations of monosaccharides and disaccharides in the revised materials and methods section.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3:</bold></p><p>(1) A possible limitation of the study is that the mechanism leading to angiogenesis in the retinal circulation and in peripheral vasculature is certainly different as diabetes is associated with excessive angiogenesis in the retina and a defect in angiogenesis in the peripheral circulation as shown by a reduced post-ischemic revascularization (see Silvestre et al.: DOI: 10.1152/physrev.00006.2013).</p></disp-quote><p>Thank you very much for your suggestions. As you said, the peripheral blood vessel model in this study does not fully represent individuals with diabetic retinopathy, which is a limitation. However, from a specific view, the phenotype and mechanism of excessive angiogenesis of peripheral blood vessels in the high glucose model may provide a reference for excessive angiogenesis in the retina; they might have similar etiology and regulation mechanisms in excessive angiogenesis.</p><disp-quote content-type="editor-comment"><p>(2) Another limitation is that angiogenesis in the embryo is not fully representative of the excessive angiogenesis observed in the diabetic retinal circulation. It would be of interest to analyse the retinal vascular tree in adult fish submitted to high glucose and to ASB.</p></disp-quote><p>In our future study, we will try to observe the angiogenesis phenotype in the diabetic retina and improve the disease model.</p><disp-quote content-type="editor-comment"><p>(3) Line 52: &quot;Endothelial cell dysfunction (ECD)&quot; instead of &quot;Endothelial dysfunction (ECD)&quot;.</p></disp-quote><p>We’ve made the correction in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(4) The authors should elaborate more on the observation showing that L-glucose, D-mannose, D-ribose, and L-arabinose, which could not be digested by animals, also induce excessive angiogenesis. Is the effect indirect?</p></disp-quote><p>In the current manuscript, we conducted an in vivo live imaging analysis to show the phenotype of excessive angiogenesis caused by those noncaloric monosaccharides. However, we did not find differences in the phenotypes of embryos treated with noncaloric and caloric monosaccharides. Therefore, we supposed that the mechanisms underlying the phenotypes were similar. The effect might be indirect.</p></body></sub-article></article>